Жените, които вече са на антикоагулантна терапия, изискват внимателна преоценка с оглед ползата и риска от ХЗТ.
If breakthrough bleeding or spotting appears after some time on therapy, or continues after treatment has been discontinued, the reason should be investigated, which may include endometrial biopsy to exclude endometrial malignancy.